InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Increased Bioavailabilty for Flagship THC/CBD-Infused Cream
March 22, 2021

InvestorNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Increased Bioavailabilty for Flagship THC/CBD-Infused Cream

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, has reached another technological milestone in the proprietary manufacturing process for its patented, disruptive Hourglass(TM) time-release THC+ cannabinoid delivery cream. In the announcement, the company noted that continued research and analysis of the manufacturing process have led to a substantial reduction in the size of the cream’s THC/CBD-infused particles. The mean particle size now measures 8.2 microns compared to previous samples, which averaged 33.1 and 29.9 microns. The company consistently analyzes the process with the intent of reducing the size of the infused particles, which leads to an increased bioavailability of Hourglass’ active ingredients. “We constantly strive to improve the quality of our Hourglass time-release THC+ cannabinoid delivery cream so our clientele is always the beneficiary of the best possible full-spectrum entourage experience we can deliver,” said Grapefruit CEO Bradley Yourist in the press release. “We performed several particle size analyses on the structure of the Hourglass cream as part of our manufacturing protocols in an effort to fine tune the process and produce a cream capable of delivering the best possible experience to Hourglass users. Our efforts have paid dividends. We are currently in the process of adapting our proprietary manufacturing protocols to our new hemp-derived CBD cream. No CBD competitor’s topical products will be able match the consistency and technology of our hemp-derived CBD creams to deliver Hourglass’ stellar results.”

To view the full press release, visit https://ibn.fm/46PbL

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).